A Multiple stiffness It is a nervous disease and autoimmune rights that displays the central nervous system and mainly affects people between the ages of 18 and 55, according to the Ministry of Health. The disease has no treatment and is considered rare, but a new treatment available in the uniform health system (SUS) can provide a larger process of patients and improve the quality of life.
Medicine CladribinaKnown as the commercial name MAVENTIt was incorporated into the public health system in February, which is the first oral treatment in the short term to treat multiple sclerosis.
The drug was launched in Brazil in 2020, and it contains a short -term dose, with 20 days of management over two years of treatment, with the event supported by at least four years, according to a clinical study. A single drug disk can be found in pharmacies for up to $ 19,000, while the distribution in SUS makes the treatment free.
“The introduction of Cladribine into Sus is really a very important step, because it brings cutting to all Brazilians – and we know that most of the population cannot reach health plans,” says Guilherme Olival, a neurologist, a multi -sclerotic specialist. CNN.
“This is an oral medicine that works as an introductory treatment, that is, you use it for a short period of time and work for a long time for years, without the need to take the medicine,” explains Ulyal. “This brings an advantage from the logistical point of view to Sus and brings advantages to the patient, because it is not vulnerable to the long side effects.”
In general, the disease can be treated with corticosteroids in its acute phase, to treat encephalitis, and with medications that prevent The immune system To attack Melina’s minors, which surrounds the neurons through which the electrical impulses are responsible for controlling the body’s functions.
These medications may be injected or heated, which can be applied in the monthly, weekly, or even daily frequency depending on treatment. “Oral medicine brings greater comfort to the patient,” says Olival.
Who refers to medicine?
MAVENCLAD is referred to for adult patients with a very active multiple stiffness, that is, a form of disease that causes frequent outbreaks and detected encephalitis in tests like MRI. In Sus, the drug is indicated when the replacement or contraindications of other treatments is needed, and it is available under the prescription.
The drug is invalid for people with active tuberculosis or hepatitis, who suffer from weakening of the immune system or who suffer from immunosuppressive treatment, who are undergoing cancer treatment, who suffer from moderate or serious problems in the kidneys and for pregnant women or breastfeeding.
Understanding what is multiple sclerosis
Multiple nervous sclerosis is an autoimmune nervous disease that weakens the central nervous system and can lead to changes in vision, balance and muscle ability. The most common symptoms include:
- Visual loss (opticitis);
- Reducing or losing parties (partial paralysis);
- Paesthestia sense;
- Coordination and balance function, spinal cord inflammation (marrow inflammation);
- Cognitive and behavioral changes.
Patients may experience changes in speech and swallowing, fatigue and problems in the urinary tract and digestive system.
One of the challenges of studying multiple sclerosis is to determine the cause of the disease. Until now, science does not have an answer about what leads to the deterioration of the sheath of myelin. The assumptions consider that work against the tissues of the nervous system is caused by the immune system itself, according to the genetic preparation.
